Progyny (NASDAQ:PGNY) Updates Q4 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter 2024 earnings guidance on Tuesday. The company provided EPS guidance of 0.310-0.350 for the period, compared to the consensus EPS estimate of 0.140. The company issued revenue guidance of $266.2 million-$281.2 million, compared to the consensus revenue estimate of $292.7 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Progyny Stock Up 0.7 %

Progyny stock opened at $17.18 on Wednesday. Progyny has a 52 week low of $13.93 and a 52 week high of $42.08. The stock has a 50-day moving average price of $17.88 and a 200 day moving average price of $23.62. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 27.27, a price-to-earnings-growth ratio of 1.61 and a beta of 1.44.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 target price on shares of Progyny in a research report on Tuesday, October 1st. Leerink Partnrs cut shares of Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lowered their price target on shares of Progyny from $31.00 to $22.00 and set an “overweight” rating on the stock in a report on Thursday, September 19th. BTIG Research cut Progyny from a “buy” rating to a “neutral” rating in a research report on Wednesday, August 7th. Finally, Canaccord Genuity Group cut their price objective on Progyny from $24.00 to $18.00 and set a “hold” rating for the company in a research report on Friday, September 20th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $27.73.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.